Inventor · disambiguated record
Karen Mclachlan
Also filed as: MCLACHLAN KAREN · MCLACHLAN KAREN RETTA
8 granted patents·15 pending applications·313 citations·filing 1997–2023
90Inventor score
Top patents by PatentIndex Score
23 records- 0195US11571477B2Anti-VLA-4 antibodiesBIOGEN MA INC·Filed 2021·Granted Feb 7, 2023·2 cites·3 claims
- 0293US6413777B1Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameIDEC PHARMA CORP·Filed 1999·Granted Jul 2, 2002·120 cites·6 claims
- 0391US10335485B2Anti-VLA-4 antibodiesBIOGEN MA INC·Filed 2017·Granted Jul 2, 2019·7 cites·6 claims
- 0491US5830698AMethod for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameIDEC PHARMA CORP·Filed 1997·Granted Nov 3, 1998·76 cites·38 claims
- 0590US7235360B2Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameBIOGEN IDEC INC·Filed 2004·Granted Jun 26, 2007·24 cites·41 claims
- 0688US6841383B2Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameIDEC PHARMA CORP·Filed 2002·Granted Jan 11, 2005·17 cites·16 claims
- 0787US11083791B2Anti-VLA-4 antibodiesBIOGEN MA INC·Filed 2019·Granted Aug 10, 2021·4 cites·22 claims
- 0884US5998144AMethod for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameIDEC PHARMA CORP·Filed 1998·Granted Dec 7, 1999·63 cites·45 claims
- 0981US2024100155A1Anti-vla-4 antibodiesBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 1061US2007071674A1Polynucleotides encoding novel isoforms of IGSF9MCLACHLAN KAREN·Filed 2006·Application pending·0 cites
- 1160US2009047668A1Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the sameBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 1258US2004258616A1Compositions and methods for treating cancer using IGSF9 and LIV-1IDEC PHARMA CORP·Filed 2004·Application pending·0 cites
- 1355US2014161794A1Anti-vla-4 antibodiesLUGOVSKOY ALEXEY·Filed 2011·Application pending·0 cites
- 1454US2005239700A1Treatment of cancer using antibodies to LRRC15BIOGEN IDEC INC·Filed 2004·Application pending·0 cites
- 1554US2008213166A1Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon CarcinomasBIOGEN IDEC INC·Filed 2003·Application pending·0 cites
- 1650US2009047737A1Human LY6-Big Molecules and Methods of UseBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 1745US2012064080A1Human LY6-Big Molecules and Methods of UseCHU PETER·Filed 2011·Application pending·0 cites
- 1843US2007073047A1Genes overexpressed by ovarian cancer and their use in developing novel therapeuticsBIOGEN IDEC INC·Filed 2003·Application pending·0 cites
- 1943US2006089493A1Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomasBIOGEN IDEC INC·Filed 2003·Application pending·0 cites
- 2042US2006204503A1Treatment of cancer using antibodies to polypeptides differentially expressed in human lung tumorsBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 2140US2002051990A1Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomasFiled 2001·Application pending·0 cites
- 2237US2008299042A1Membrane Associated MoleculesBIOGEN IDEC INC·Filed 2005·Application pending·0 cites
- 2337US2010266587A1Compositions and Methods to Treat Acute Myelogenous LeukemiaBIOGEN IDEC INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →